172 related articles for article (PubMed ID: 21732346)
1. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
Hofvind S; Sakshaug S; Ursin G; Graff-Iversen S
Int J Cancer; 2012 Jun; 130(12):2930-8. PubMed ID: 21732346
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of breast cancer before and after implementation of mammography screening].
Hofvind S; Sørum R; Haldorsen T; Langmark F
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
4. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
5. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
Weedon-Fekjær H; Bakken K; Vatten LJ; Tretli S
BMJ; 2012 Jan; 344():e299. PubMed ID: 22290099
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
Suhrke P; Zahl PH
Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer incidence and hormone replacement therapy in Canada.
De P; Neutel CI; Olivotto I; Morrison H
J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
10. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
[TBL] [Abstract][Full Text] [Related]
11. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
Lund E; Mode N; Waaseth M; Thalabard JC
BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.
Hemminki E; Kyyrönen P; Pukkala E
Maturitas; 2008 Dec; 61(4):299-304. PubMed ID: 18996655
[TBL] [Abstract][Full Text] [Related]
13. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
14. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation.
Crocetti E; Buzzoni C; Falcini F; Cortesi L; De Lisi V; Ferretti S; Tumino R; Russo A; Paci E
Breast J; 2010; 16(4):350-5. PubMed ID: 20443789
[TBL] [Abstract][Full Text] [Related]
15. Time trends in breast cancer and menopause hormone therapy use in New Zealand.
Farmer R; Fenton A
Climacteric; 2016; 19(1):42-8. PubMed ID: 26574628
[TBL] [Abstract][Full Text] [Related]
16. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer mortality in Norway after the introduction of mammography screening.
Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
[TBL] [Abstract][Full Text] [Related]
18. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Bray F; Klint A; Hakulinen T; Storm HH; Engholm G
Acta Oncol; 2010 Jun; 49(5):624-31. PubMed ID: 20429724
[TBL] [Abstract][Full Text] [Related]
19. Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.
Ereman RR; Prebil LA; Mockus M; Koblick K; Orenstein F; Benz C; Clarke CA
BMC Public Health; 2010 Apr; 10():228. PubMed ID: 20433756
[TBL] [Abstract][Full Text] [Related]
20. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
